Catalyst Wire Dossier Catalyst Wire Dossier

CEA-targeted CAR-T therapy

CAR-T cell therapy targeting carcinoembryonic antigen (CEA) · Chongqing Precision Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CEA-targeted CAR-T therapy, covering 2022-09-13 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]

See pricing